Loading clinical trials...
Loading clinical trials...
The main purpose of this multicenter, randomized, double-blind, placebo-controlled Phase 2b study is to investigate the safety and efficacy of GIA632 in participants with NSV and to identify the optim...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Novartis Pharmaceuticals
NCT07533019 · Vitiligo, Non-Segmental Vitiligo (NSV)
NCT06991972 · Vitiligo, Non-segmental Vitiligo
NCT06511739 · Non-segmental Vitiligo
NCT06493578 · Non-segmental Vitiligo
NCT06113328 · Non-segmental Vitiligo
Cahaba Derm and skin hlth ctr 27
Birmingham, Alabama
Miami Derm and Laser Institute
Miami, Florida
Revival Research Institute
Troy, Michigan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions